Combined treatment with a β-catenin inhibitor and a BET inhibitor had strong cytotoxic effects in in vivo and in vitro post-myeloproliferative neoplasms (MPN) AML blast progenitor cells (BPCs) [121,122]. Here, DNER is linked to myeloproliferative disorder.